{"disease":{"id":"tardive-dyskinesia-td","name":"tardive dyskinesia td"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03891862","title":"Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Neurocrine Biosciences","has_results":true},{"nct_id":"NCT06731868","title":"Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT03698331","title":"The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Neurocrine Biosciences","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}